PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12663234-3	2003	METHODS: Thirty subjects with NASH and elevated alanine aminotransferase (ALT) levels received rosiglitazone, 4 mg twice daily for 48 weeks; the preliminary results presented here were obtained at 24 weeks.	Rosiglitazone	95-108	glutamic--pyruvic transaminase	Homo sapiens	48-72	
17074328-2	2007	Rosiglitazone significantly decreased serum C-reactive protein levels, white blood cell count, and alanine aminotransferase enzyme activity but did not affect lipid or blood pressure levels.	Rosiglitazone	0-13	glutamic--pyruvic transaminase	Homo sapiens	99-123